CME Webcast Teaches on Preventive Cardiology

OSUWexnerbloglogo2014 CME Webcast Teaches on Preventive Cardiology. The best way to improve outcomes in cardiovascular disease is to not get it in the first place and today on MedNet21, we are going to show you what you can do to prevent heart disease in your patients. Let me welcome today’s guests. Dr. Wesley Milks is a cardiologist and Assistant Professor of Internal Medicine and Kelly Bartsch is a pharmacist specializing in lipid management.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW
the mechanisms of action of the major medication classes utilized in the 2018 multi-society cholesterol guidelines; and UNDERSTAND the influence of the new cardiovascular outcomes trials for ezetimibe and the PCSK9 inhibitors on the new cholesterol guidelines; DEMONSTRATE understanding of key atherosclerotic risk and risk-enhancing factors as well as of recent pivotal lipid lowering treatment guidelines; and SELECT the appropriate target of lipid lowering therapy (e.g. LDL-C or non-HDL-C) with respect to the patient’s comorbid metabolic conditions.

You’ll also learn about the following:

  • Cholesterol level goals
  • Indications for medical treatment of lipids
  • Follow-up of patients started on cholesterol lowering drugs
  • Monitoring of cholesterol lowering drugs
  • CRP and other inflammatory markers

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Drugs for Lipid Management

OSUWexnerbloglogo2014 Learn About New Drugs for Lipid Management. Managing hyperlipidemia used to be so easy. If a patient’s total cholesterol was greater than 200, then we started them on lovastatin to reduce it. But things are a lot more complicated now. There isn’t a single cholesterol target for all patients and we have gone way beyond statins as the only game in town for cholesterol management. On this CME webcast, we’re going to update you on the newest developments in lipid management. What tests to order, who to treat and which drugs to use. Joining our moderator in the studio is cardiologist and Associate Professor of Internal Medicine, Dr. John Larry and pharmacist and Assistant Professor of Pharmacy, Melissa Snider.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW updates in approaches to treatment of dyslipidemia; DISCUSS recent evidence for non-statin lipid lowering therapies; DISCUSS place in therapy of available lipid lowering therapies; and REVIEW clinical approach to statin intolerance.

You’ll also learn about the following:

  • Patient-specific cholesterol targets
  • Multidisciplinary lipid clinics at the OSU Wexner Medical Center
  • The expanding role of pharmacists in outpatient clinical practice
  • Diet and cholesterol

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get An Epilepsy Update Viewing On-line CME Webcast

OSUWexnerbloglogo2014 Get An Epilepsy Update Viewing On-line CME Webcast. Today, the EEG is one of the most commonly performed tests in neurology and one of its primary uses is in the diagnosis and study of seizures. On this CME Webcast, we are going to review the basics of seizures and epilepsy: how to diagnose it, how to classify it, and how to treat it, including new non-pharmacologic therapies that are revolutionizing seizure management. We’re pleased to welcome Professor of Neurology and epilepsy specialist, Dr. William Bell.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the basic diagnosis of spells and seizures; LEARN basic medication treatment for epilepsy; and REVIEW advanced treatment options for refractory epilepsy including epilepsy surgery and devices.

You’ll also learn about the following:

  • Acute management of the patient having a seizure
  • Anti-epileptic drugs
  • Choosing between medication, surgery, or a vagal nerve stimulator
  • Advising patients about driving

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.